Birdwatch Note Rating
2023-07-12 09:24:22 UTC - NOT_HELPFUL
Rated by Participant: 0D0044D0666FBBE4559F6855472FC30D9BD1AF0C2E702A87764EDC541A4E8D2C
Participant Details
Original Note:
A two-shot course of Pfizer Inc.’s vaccine may have just 22.5% efficacy against symptomatic infection with the omicron variant, but can thwart severe disease, according to laboratory experiments in South Africa. https://www.bloomberg.com/news/articles/2021-12-11/pfizer-course-has-23-efficacy-vs-omicron-in-s-african-study
All Note Details